CTIS.eu › Cities › Germany › Munich
Munich
Germany
1,080 total trials
467 recruiting
Filter these 1,080 trials by phase, condition, sponsor and more.
Open in Search →
2024-511738-11-00
5
2024-12-18
Psoriatic arthritis
2024-511881-35-00
5
2024-12-17
Prurigo Nodularis
2024-513208-32-00
5
2024-12-16
Chronic Spontaneous Urticaria
2024-515389-15-00
4
2024-12-13
Mitochondrial encephalomyopathy, lactic acidosis, and stroke-like epis
2024-511378-60-00
5
2024-12-11
Myotonic Dystrophy Type 1
2024-510944-30-00
10
2024-11-22
Diabetic Macular Edema
2024-511482-11-00
5
2024-11-20
Dry Age-Related Macular Degeneration (Dry AMD)
2023-510525-15-00
4
2024-11-18
active antineutrophilic cytoplasmic antibody (ANCA) associated vasculi
2024-510581-17-00
4
2024-11-05
Adult subjects with New York Heart Association (NYHA) Class III conges
2022-501457-37-00
5
2024-10-28
Myeloid Leukemia in Children with Down Syndrome
2023-508636-61-00
5
2024-10-24
Crohn’s Disease
2024-510584-37-00
4
2024-10-22
Systemic Lupus Erythematosus
2024-515936-62-00
9
2024-10-10
Patients with advanced or metastatic gastrointestinal (GI) tumors.
2024-516212-24-00
4
2024-10-08
Chronic Myeloid Leukemia
2024-511212-24-00
9
2024-10-07
Advanced solid tumors
2023-506717-21-00
9
2024-10-02
Breast Cancer
2023-504753-12-00
5
2024-10-01
Lung Cancer, Non-Small Cell
2023-510366-28-00
4
2024-09-25
Progressive supranuclear palsy (PSP)
2023-507851-31-00
5
2024-09-23
Immunoglobulin A Nephropathy (IgAN)
2022-502605-15-00
4
2024-09-16
Participants with transthyretin amyloid cardiomyopathy (ATTR CM)
2023-508219-21-00
5
2024-09-12
BTC - Biliary Tract Cancer
2023-509190-23-00
5
2024-09-03
Atherosclerotic Cardiovascular Disease
Elevated lp(a)
2024-511260-84-00
4
2024-09-03
Atopic Dermatitis
2024-510908-37-00
5
2024-08-28
KRAS G12C-Positive Advanced or Metastatic Non-Small Cell Lung Cancer (
Showing 577–600 of 1,080 trials